Sep 22, 2022 10:28 AM (GMT+8) · EqualOcean
BioGeometry (Chinese: 百奥几何) announced its completion of the angel financing round worth USD 10 million recently. Gaorong Capital (Chinese: 高榕资本) served as the exclusive investor for this round. The funds will be used for the team expansion. Founded in 2021, BioGeometry focuses on the research and development of macromolecule drugs with its own AI-powered technology. The company has released its first open-source machine learning platform for macromolecule drug discovery, TorchProtein. This platform open-sources a general framework for deep learning to model macromolecules, the first pre-trained large model based on protein 3D geometry, and a standard dataset dedicated to evaluating the effectiveness of deep learning to model proteins.